GENEVA, Aug. 6 -- THE JOHNS HOPKINS UNIVERSITY (3400 N. Charles StreetBaltimore, Maryland 21218) filed a patent application (PCT/US2025/012592) for "MULTIVALENT DENDRIMER CONJUGATED PROTACS FOR CELL-TARGETED TARGETED PROTEIN DEGRADATION" on Jan 22, 2025. With publication no. WO/2025/160171, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RANGARAMANUJAM, Kannan (c/o Dendrimer Nanomedicine Research Group, The Johns Hopkins University400 N. BroadwayBaltimore, Maryland 21231), LIYANAGE, Wathsala (c/o Dendrimer Nanomedicine Re...